State Street Corp Genocea Biosciences, Inc. Transaction History

State Street Corp

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.01 - $1.38 $243 - $33,649	-24,384 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$0.96 - $1.35 $4,512 - $6,345	4,700 Added 23.88%	24,384 $30,000
Q2 2021 Aug 16, 2021	BUY	$2.06 - $2.82 $40,549 - $55,508	19,684 New	19,684 $46,000

10K

Ticker GNCA
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,783,500
Description
Genocea Biosciences, Inc., a biopharmaceutical company, discovers and develops novel cancer immunotherapies. The company uses its proprietary discovery platform, ATLAS, which profiles each patient's CD4+ and CD8+ T cell immune responses to every target or antigen identified by next-generation sequencing of that patient's tumor. Its products incl...

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

Stay updated on State Street Corp with notifications on news.